In this week’s Video Forum, Joe DePinto, head of cell, gene and advanced therapies at McKesson, talks about the company’s new InspiroGene division and the impact it is expected to have on the biotech marketplace. Precision dispensing and patient management, the product pipeline for advanced therapies, and recent research from InspiroGene were among the topics discussed.
Video Forum: Joe DePinto, McKesson
New division takes aim at cell and gene therapies.

Latest

WBA shareholders overwhelmingly approve acquisition by Sycamore Partners
Ninety-six percent of shareholders and 95% of unaffiliated shareholders at a special meeting voted in favor of the deal.c

Retail sales dip in June amid consumer uncertainty, NRF reports
Tariff concerns and economic unease drive first monthly sales decline since February.
As prices rise, moms take lead family spending decisions
The study revealed that rising costs and an overload of choices are the primary stressors for mothers.

Mall Traffic eases in June following spring surge
Indoor malls continued to demonstrate the strongest performance among shopping formats.